global
New Post

The Growing Role of Quantitative PET Imaging in Alzheimer’s Disease

The treatment landscape for Alzheimer’s disease is changing. With the introduction of disease-modifying anti-amyloid therapies, clinicians need reliable
READ MORE
The Growing Role of Quantitative PET Imaging in Alzheimer’s Disease

See how integrated AI and qMRI can
transform your Neuroimaging workflow

SyntheticMR

  • Storgatan 11
  • SE-582 23 Linköping, Sweden
  • info@syntheticmr.com 
Customer Support

SyntheticMR AB (publ) develops and markets innovative imaging solutions that enhance neuroimaging workflow efficiency and diagnostic precision. SyntheticMR’s SyMRI® solution measures brain absolute tissue properties and generates multiple contrast-weighted images, performs automatic segmentation of biomarkers, and delivers quantitative data in a single fast scan. Combinostics, a SyntheticMR company, offers the AI-powered cNeuro® suite of products that help clinicians make a difference in the lives of patients with neurological disorders.

Our products are CE-marked and FDA-approved. We are listed on Spotlight Stock Market Exchange in Stockholm. SyntheticMR is headquartered in Linköping, Sweden, with an additional office in Tampere, Finland. For more information, please visit syntheticmr.com and combinostics.com.

©2026 SyntheticMR. All rights reserved